ESPERITE pioneers first treatment worldwide of Cerebral Palsy using two types of stem cells

February 23, 2015 Group News
shutterstock_75799198

ESPERITE pioneers first treatment worldwide of Cerebral Palsy using two types of stem cells

CryoSave, part of ESPERITE, is the only private cord blood bank sponsoring a GCP clinical trial according to GMP-ATMP international guidelines

CryoSave leads and sponsors a multicentre clinical trial following GCP-ICH standards, for investigation of new treatment of Cerebral Palsy using dual infusion of two types of stem cells derived from umbilical cord blood and cord tissue processed by CryoSave

Geneva, Switzerland – 23 February 2015

read more

Child with cerebral palsy treated with umbilical cord blood derived autologous stem cells

December 12, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe announces that on December 10th 2013 a 4-year-old girl in Spain received an infusion of stem cells derived from her own umbilical cord blood for the treatment of her cerebral palsy. Cerebral palsy is one of the main areas of investigation of umbilical cord blood stem cell therapies.

read more

In the year of the 25th anniversary of the first umbilical cord blood transplant Cryo-Save reaches 250,000 stored stem cell samples

October 7, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that it reached the major milestone of storing more than 250,000 stem cell samples since its foundation in 2000. At the same time, October 2013 marks the 25th anniversary of the first umbilical cord blood transplant performed by Dr. Eliane Gluckman in October 1988.

read more

New freezing procedure increases availability of cord blood stem cell transplants for patients

February 7, 2013 Group News

A large enough number of stem cells are needed to ensure the success of a cord blood transplant. However, the quantity of stem cells isolated from umbilical cord blood is not always sufficient to meet that requirement. Researchers from the Etablissement Français du Sang, Aquitaine-Limousin (France) have established a method to multiply cord blood stem cells to required quantity levels. In the current study Dr. Ivanovic and co-workers (Etablissement Français du Sang Aquitaine-Limousin) and a team of Cryo-Save researchers have demonstrated that these cultured stem cells can be frozen and thawed without negatively affecting the quality of the stem cells. An important step towards successful stem cell transplants in patients for whom too few stem cells are available.

read more

Professional conferences held as part of Cryo-Save’s cord blood awareness months

September 14, 2012 Group News

Cryo-Save Group promotes the awareness of cord blood storage and stem cell therapies at several professional conferences held throughout eastern and southern Europe.

It is with great pleasure that Cryo-Save supports the awareness, research and advancement of cord blood storage and therapies by taking part in and sponsoring four major conferences in Cyprus, Bosnia-Herzegovina, Serbia and Hungary during the months of September and October.

read more

Umbilical cord blood stem cells: prime source for transplants and future regenerative medicine

November 29, 2011 Group News

The 5th ITERA Life-Sciences Consortium Symposium took place in Maastricht, the Netherlands, and showcased the progress of stem cell research and promising therapeutic applications. Thanks to solid scientific data, researchers confirmed that umbilical cord blood stem cells are one of the prime sources to be used in current stem cell transplants, ongoing research and future regenerative medicine.

Cord blood is one of the prime sources for stem cells, more and more used for stem cell transplants

read more

Cryo-Save is proud to announce the achievement of 200,000 samples stored from umbilical cord blood and umbilical cord tissue

November 22, 2011 Group News

Cryo-Save is proud to announce the storage of its 200,000th sample

This great achievement shows the successful results of Cryo-Save’s efforts in increasing the awareness of stem cell storage among the general public and the medical community. All samples stored can be considered as an outstanding source of stem cells, offering an enormous potential for treating so far incurable diseases.

read more

Cerebral palsy boy treated with own cord blood stem cells

December 14, 2010 Group News

Cryo-Save Group N.V. (Euronext: CRYO, “Cryo-Save”), Europe’s leading stem cell bank, today announces that another sample has been released. A six year old boy from Portugal went to Duke University (USA) to participate in a FDA approved clinical trial for cerebral palsy (CP). Cerebral palsy is a form of brain injury which causes physical disability and has no standard cure at the moment.

read more

Leukemia child now completely cured thanks to her own cord blood stem cells

November 26, 2010 Press Clippings

A world’s first allowed to save a young girl’s life

In 2005, the parents of a four year old girl suffering from leukemia were told their daughter’s chemotherapy had failed. The doctors had lost hope; they gave her a three months prognosis. Five years later, the girl is alive and doing well, she is even considered cured. She was infused by her own cord blood stem cells, which her parents had stored privately. This is the first time an autologous cord blood transplant has cured leukemia.

Source: Life Site News

Page 1 of 212